New research may expand engineered T-cell cancer treatment

Researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue. The scientists designed genetically engineered CAR T cells that must be activated and targeted by a small molecule adaptor. The technology has been tested in animal models.